RICHARD LEE MARTIN, LVN
Nursing at B St, San Diego, CA

License number
California 242385
Category
Nursing
Type
Licensed Vocational Nurse
Address
Address
600 B St STE 1570, San Diego, CA 92101
Phone
(619) 615-0439
(619) 615-3197 (Fax)

Professional information

Richard Martin Photo 1

Broker At Http://Www.brokercommercialloans.com

Position:
Broker at http://www.brokercommercialloans.com
Location:
Greater San Diego Area
Industry:
Real Estate
Work:
http://www.brokercommercialloans.com - Broker


Richard Martin Photo 2

Owner At Hunda Automotive Inc.

Position:
Owner at Hunda Automotive Inc.
Location:
Greater San Diego Area
Industry:
Automotive
Work:
Hunda Automotive Inc. - Owner


Richard Martin Photo 3

Owner At Rich Martin Bail Bonds

Position:
Owner at Rich Martin Bail Bonds
Location:
Greater San Diego Area
Industry:
Consumer Services
Work:
Rich Martin Bail Bonds - Owner


Richard Martin Photo 4

Inhibitors Of 4 Mediated Cell Adhesion

US Patent:
6521666, Feb 18, 2003
Filed:
Jul 19, 2000
Appl. No.:
09/619712
Inventors:
Ila Sircar - San Diego CA
Kristjan S. Gudmundsson - Raleigh NC
Richard Martin - San Diego CA
Assignee:
Tanabe Seiyaku Co., Ltd. - Osaka
International Classification:
C07C23387
US Classification:
514576, 562445


Richard Martin Photo 5

Triazole And Imidazole Derivatives For Use As Tgr5 Agonists In The Treatment Of Diabetes And Obesity

US Patent:
2012004, Feb 16, 2012
Filed:
Feb 12, 2010
Appl. No.:
13/148811
Inventors:
Venkataiah Bollu - San Diego CA, US
Brant Clayton Boren - San Diego CA, US
Jackaline Dalgard Julien - Del Mar CA, US
Brenton T. Flatt - Poway CA, US
Nadia Haq - Waltham MA, US
Sarah Hudson - San Diego CA, US
Raju Mohan - Encinitas CA, US
Michael Morrissey - Danville CA, US
Benjamin Pratt - Encinitas CA, US
Richard Martin - San Diego CA, US
Xiao-Hui Gu - Potomac MD, US
Assignee:
EXELIXIS PATENT COMPANY LLC - SAN FRANCISCO CA
International Classification:
A61K 31/5377, A61K 31/498, A61K 31/473, A61K 31/423, A61K 31/4196, C07D 233/84, C07D 413/06, C07D 403/06, C07D 403/12, C07D 249/12, A61K 31/4164, C07D 405/14, A61P 3/00, A61P 3/04, A61P 9/10, A61P 3/10, A61P 3/06, C12N 5/02
US Classification:
5142362, 435375, 514249, 514314, 514379, 514381, 514383, 514398, 544132, 544353, 546167, 548241, 548252, 5482642, 5483251
Abstract:
The present invention comprises TGR5 agonists of structural formula I,wherein X, R, R, and Rare defined herein, as well as N-oxides of them and pharmaceutically acceptable salts thereof. The invention further comprises composition comprising the compounds, N-oxides, and/or pharmaceutically acceptable salts thereof. The invention also comprises use of the compounds and compositions for treating diseases in which TGR5 is a mediator or is implicated. The invention also comprises use of the compounds in and for the manufacture of medicaments, particularly for treating diseases in which TGR5 is a mediator or is implicated.


Richard Martin Photo 6

Bileaflet Heart Valve With External Leaflets

US Patent:
5078739, Jan 7, 1992
Filed:
Jul 20, 1990
Appl. No.:
7/554902
Inventors:
Richard L. Martin - San Diego CA
Assignee:
Janus Biomedical, Inc. - Austin TX
International Classification:
A61F 224, A16K 1500, A16K 1700, A16K 2104
US Classification:
623 2
Abstract:
An improved heart valve prosthesis (20) suited for replacement of any of the four valves in the heart. The invention includes a generally annular orifice ring (22) having a fluid flow bore with a smooth inner wall (26) through which blood flows, controlled by two pivoted leaflet occluders (40), supported at the downstream edge of the orifice ring. The occluders are supported at the outboard edges of the orifice ring, overlapping the fluid flow bore and generally about each other to seal backflow and regulate flow in one direction only. Occluder travel is limited by bending moment resistance of the occluder hinge and lateral blood flow. Occluder hinges are unloaded at a point between fully opened and fully closed. The bearing surfaces between the occluder means and the annular orifice are wide enough to allow the valve to be constructed from materials of different hardnesses.


Richard Martin Photo 7

Lxr And Fxr Modulators

US Patent:
7998995, Aug 16, 2011
Filed:
Dec 7, 2007
Appl. No.:
12/517800
Inventors:
Brant Clayton Boren - San Diego CA, US
Brett B. Busch - San Diego CA, US
Xiao-Hui Gu - Potomac MD, US
Vasu Jammalamadaka - Pleasanton CA, US
Shao Po Lu - San Diego CA, US
Richard Martin - San Diego CA, US
Raju Mohan - Encinitas CA, US
Edwin Schweiger - San Diego CA, US
William C. Stevens - La Jolla CA, US
Yinong Xie - Mission Viejo CA, US
Wei Xu - Danville CA, US
Assignee:
Exelixis Patent Company LLC - South San Francisco CA
International Classification:
A61K 31/4178, A61K 31/4164, C07D 233/56, C07D 233/58, C07D 233/66, C07D 233/64
US Classification:
514397, 514398, 5483435, 5483111, 5483164, 5483215
Abstract:
Compounds of the invention are disclosed, such as compounds of formulae LX-LXIV, and pharmaceutically acceptable salts, isomers, or prodrugs thereof, which are useful as modulators of the activity of liver X receptors (LXR) and Farnesoid X receptors (FXR), where R, R, R, R, J, J, G, G, and Q are defined herein. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.


Richard Martin Photo 8

Independent Wine And Spirits Professional

Location:
Greater San Diego Area
Industry:
Wine and Spirits


Richard Martin Photo 9

Richard Martin

Location:
Greater San Diego Area
Industry:
Pharmaceuticals
Languages:
French


Richard Martin Photo 10

Lxr Modulators

US Patent:
8618154, Dec 31, 2013
Filed:
May 26, 2010
Appl. No.:
13/319937
Inventors:
Brett B. Busch - San Diego CA, US
Ellen K. Kick - Pennington NJ, US
Haiying Zhang - Pennington NJ, US
Venkataiah Bollu - San Diego CA, US
Richard Martin - San Diego CA, US
Raju Mohan - Encinitas CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
Exelixis Patent Company LLC - South San Francisco CA
International Classification:
A61K 31/425, C07D 233/54
US Classification:
514400, 5483421
Abstract:
Compounds, pharmaceutically acceptable salts, isomers, or prodrugs thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.